respected medical journal says avastin is just as effective at tackling wet age-related macular degeneration as the current treatment , lucentis .
drug company novartis has allegedly tried to block trials aimed at promoting a ‘ cheap , safe and effective’ treatment for sight loss which would save the nhs .